Metformin in Patients With COVID-19: A Systematic Review and Meta-Analysis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metformin in Patients With COVID-19: A Systematic Review and Meta-Analysis
Authors
Keywords
-
Journal
Frontiers in Medicine
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-08-19
DOI
10.3389/fmed.2021.704666
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Predictors of clinical deterioration in non-severe patients with COVID-19: a retrospective cohort study
- (2021) Yitao Zhang et al. CURRENT MEDICAL RESEARCH AND OPINION
- Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials
- (2021) Suetonia C Palmer et al. BMJ-British Medical Journal
- Metformin Use Is Associated With Reduced Mortality in a Diverse Population With COVID-19 and Diabetes
- (2021) Andrew B. Crouse et al. Frontiers in Endocrinology
- Adverse outcomes in COVID-19 and diabetes: a retrospective cohort study from three London teaching hospitals
- (2021) Chioma Izzi-Engbeaya et al. BMJ Open Diabetes Research & Care
- High‐sensitivity C‐reactive protein and risk of type 2 diabetes: a nationwide cohort study and updated meta‐analysis
- (2021) Xue Yang et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Association of metformin with susceptibility to COVID-19 in people with Type 2 diabetes
- (2021) Jingya Wang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Outpatient metformin use is associated with reduced severity of COVID‐19 disease in adults with overweight or obesity.
- (2021) Carolyn T. Bramante et al. JOURNAL OF MEDICAL VIROLOGY
- Long-Acting Metformin Vs. Metformin Immediate Release in Patients With Type 2 Diabetes: A Systematic Review
- (2021) Jixue Tan et al. Frontiers in Pharmacology
- Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England
- (2021) Kamlesh Khunti et al. Lancet Diabetes & Endocrinology
- Metformin and cardiorenal outcomes in diabetes: A reappraisal
- (2020) John R. Petrie et al. DIABETES OBESITY & METABOLISM
- CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM – 2020 EXECUTIVE SUMMARY
- (2020) Alan J. Garber et al. Endocrine Practice
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Metformin Treatment Was Associated with Decreased Mortality in COVID-19 Patients with Diabetes in a Retrospective Analysis
- (2020) Pan Luo et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- COVID-19 and diabetes: Is metformin a friend or foe?
- (2020) Francesco Ursini et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study
- (2020) Bertrand Cariou et al. DIABETOLOGIA
- High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation
- (2020) Arthur Simonnet et al. Obesity
- SARS-CoV-2 infection: The role of cytokines in COVID-19 disease
- (2020) Víctor J. Costela-Ruiz et al. CYTOKINE & GROWTH FACTOR REVIEWS
- A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward
- (2020) Bo Wang et al. Journal of Hematology & Oncology
- Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study
- (2020) Andrew Clark et al. Lancet Global Health
- Clinical Characteristics and Disease Progression in Early-Stage COVID-19 Patients in South Korea
- (2020) Min Hyuk Choi et al. Journal of Clinical Medicine
- Metformin Is Associated with Higher Incidence of Acidosis, but Not Mortality, in Individuals with COVID-19 and Pre-existing Type 2 Diabetes
- (2020) Xu Cheng et al. Cell Metabolism
- Risk of Metformin in Patients With Type 2 Diabetes With COVID‐19: A Preliminary Retrospective Report
- (2020) Yongchao Gao et al. CTS-Clinical and Translational Science
- Mortality risk with preadmission metformin use in patients with COVID‐19 and diabetes: A meta‐analysis
- (2020) Chia Siang Kow et al. JOURNAL OF MEDICAL VIROLOGY
- Metformin is associated with Decreased 30-day Mortality among Nursing Home Residents Infected with SARS-CoV2
- (2020) Michelle Lally et al. Journal of the American Medical Directors Association
- Risk factors for hospital admission among COVID-19 patients with diabetes. A study from Saudi Arabia
- (2020) Ayman Al Hayek et al. SAUDI MEDICAL JOURNAL
- Risk Factors for Poor Outcomes of Diabetes Patients With COVID-19: A Single-Center, Retrospective Study in Early Outbreak in China
- (2020) Nan Zhang et al. Frontiers in Endocrinology
- Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study
- (2020) Luis M. Pérez-Belmonte et al. BMC Medicine
- Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19
- (2020) Jean-Daniel Lalau et al. DIABETES & METABOLISM
- Association of metformin with mortality or ARDS in patients with COVID-19 and type 2 diabetes: a retrospective cohort study
- (2020) Nan Jiang et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Is there an association between metformin use and clinical outcomes in diabetes patients with COVID-19?
- (2020) Jun Young Do et al. DIABETES & METABOLISM
- Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017
- (2019) et al. JAMA Oncology
- Visit-to-Visit HbA1c Variability Is Associated With Cardiovascular Disease and Microvascular Complications in Patients With Newly Diagnosed Type 2 Diabetes
- (2019) Sheyu Li et al. DIABETES CARE
- 2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2019) John B. Buse et al. DIABETES CARE
- AMPK Phosphorylation of ACE2 in Endothelium Mitigates Pulmonary Hypertension
- (2018) Jiao Zhang et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013
- (2017) Limin Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Sex-dependent difference in the effect of metformin on colorectal cancer-specific mortality of diabetic colorectal cancer patients
- (2017) Jung Won Park et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Metformin and the gastrointestinal tract
- (2016) Laura J. McCreight et al. DIABETOLOGIA
- Metformin Treatment and Homocysteine: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- (2016) Qianying Zhang et al. Nutrients
- Vitamin B12 Status in Metformin Treated Patients: Systematic Review
- (2014) Qilin Liu et al. PLoS One
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
- (2010) Andreas Stang EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation